Publications


2017

Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.

Barrdahl M, Rudolph A, Hopper JL, Southey MC, Broeks A, Fasching PA, Beckmann MW, Gago-Dominguez M, et al.


Int J Cancer
201708
https://pubmed.ncbi.nlm.nih.gov/28670784/

Risk and predictors of psoriasis in patients with breast cancer: a Swedish population-based cohort study.

Yang H, Brand JS, Li J, Ludvigsson JF, Ugalde-Morales E, Chiesa F, Hall P, Czene K.


BMC Med
201708
https://pubmed.ncbi.nlm.nih.gov/28797265/

Common shared genetic variation behind decreased risk of breast cancer in celiac disease.

Ugalde-Morales E, Li J, Humphreys K, Ludvigsson JF, Yang H, Hall P, Czene K.


Sci Rep
201707
https://pubmed.ncbi.nlm.nih.gov/28725034/

Assessment of Breast Cancer Risk Factors Reveals Subtype Heterogeneity.

Holm J, Eriksson L, Ploner A, Eriksson M, Rantalainen M, Li J, Hall P, Czene K.


Cancer Res
201705
https://pubmed.ncbi.nlm.nih.gov/28512241/

Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk.

Day FR, Thompson DJ, Helgason H, Chasman DI, Finucane H, Sulem P, Ruth KS, Whalen S, et al.


Nat Genet
201704
https://pubmed.ncbi.nlm.nih.gov/28436984/

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.

Fagerholm R, Khan S, Schmidt MK, García-Closas M, Heikkilä P, Saarela J, Beesley J, Jamshidi M, et al.


Oncotarget
201703
https://pubmed.ncbi.nlm.nih.gov/28179588/

BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.

Shimelis H, Mesman RLS, Von Nicolai C, Ehlen A, Guidugli L, Martin C, Calléja FMGR, Meeks H, et al.


Cancer Res
201703
https://pubmed.ncbi.nlm.nih.gov/28283652/

Time-dependent risk of depression, anxiety, and stress-related disorders in patients with invasive and in situ breast cancer.

Yang H, Brand JS, Fang F, Chiesa F, Johansson AL, Hall P, Czene K.


Int J Cancer
201702
https://pubmed.ncbi.nlm.nih.gov/27859142/

A clinical model for identifying the short-term risk of breast cancer.

Eriksson M, Czene K, Pawitan Y, Leifland K, Darabi H, Hall P.


Breast Cancer Res
201701
https://pubmed.ncbi.nlm.nih.gov/28288659/

2016

Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry.

Wen W, Shu XO, Guo X, Cai Q, Long J, Bolla MK, Michailidou K, Dennis J, Wang Q, et al.


Breast Cancer Res
201612
https://pubmed.ncbi.nlm.nih.gov/27931260/

Differences in mammographic density between Asian and Caucasian populations: a comparative analysis.

Rajaram N, Mariapun S, Eriksson M, Tapia J, Kwan PY, Ho WK, Harun F, Rahmat K, Czene K, et al.


Breast Cancer Res Treat
201611
https://pubmed.ncbi.nlm.nih.gov/27864652/

rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk.

Liu J, Lončar I, Collée JM, Bolla MK, Dennis J, Michailidou K, Wang Q, Andrulis IL, et al.


Sci Rep
201611
https://pubmed.ncbi.nlm.nih.gov/27845421/

Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients. 

Brand JS, Hedayati E, Humphreys K, Ludvigsson JF, Johansson AL, Bergh J, Hall P, Czene K.


Clin Cancer Res
201611
https://pubmed.ncbi.nlm.nih.gov/27803117/

Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. 

Hamdi Y, Soucy P, Adoue V, Michailidou K, Canisius S, Lemaçon A, Droit A, Andrulis IL, et al.


Oncotarget
201610
https://pubmed.ncbi.nlm.nih.gov/27792995/

Common diseases as determinants of menopausal age.

Li J, Eriksson M, Czene K, Hall P, Rodriguez-Wallberg KA.


Hum Reprod
201610
https://pubmed.ncbi.nlm.nih.gov/27798047/

Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study.

Brand JS, Hedayati E, Bhoo-Pathy N, Bergh J, Hall P, Humphreys K, Ludvigsson JF, Czene K.


Cancer
201610
https://pubmed.ncbi.nlm.nih.gov/27727456/

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.

Muranen TA, Greco D, Blomqvist C, Aittomäki K, Khan S, Hogervorst F, Verhoef S, Pharoah PD, et al.


Genet Med
201610
https://pubmed.ncbi.nlm.nih.gov/27711073/

Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study. 

Strand F, Humphreys K, Cheddad A, Törnberg S, Azavedo E, Shepherd J, Hall P, Czene K.


Breast Cancer Res
201610
https://pubmed.ncbi.nlm.nih.gov/27716311/

Risk of hospitalisation and death due to bone fractures after breast cancer: a registry-based cohort study.

Colzani E, Clements M, Johansson AL, Liljegren A, He W, Brand J, Adolfsson J, Fornander T, Hall P, Czene K.


Br J Cancer
201610
https://pubmed.ncbi.nlm.nih.gov/27701383/

Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium. 

Muranen TA, Blomqvist C, Dörk T, Jakubowska A, Heikkilä P, Fagerholm R, Greco D, Aittomäki K, et al.


Breast Cancer Res
201610
https://pubmed.ncbi.nlm.nih.gov/27716369/